MedTrace Logo

Palliative Outcome Evaluation Muenster I

NCT03286127 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 347

Last updated 2018-10-09

No results posted yet for this study

Summary

For patients with an advanced disease and their families an excellent and compassionate care is essential. However, in hospitals optimal end-of-life care is not yet fully realized and patient's needs are often not met. Palliative care is able to increase patients' quality of life and to carefully meet their and their families' needs.

To improve the awareness of unmet needs patient-reported outcome measurement has been the pivot of latest palliative care research. Besides the improvement of care outcome measurement allows the evaluation of the quality of palliative care and comparisons on a national and international level.

The aim of the present study is to evaluate the quality of palliative care in different settings (palliative care unit, inpatient and outpatient consultation teams) using the Integrated Palliative Care Outcome Scale (IPOS). The IPOS has been lately developed as improved follow-up version of the Palliative Care Outcome Scale (POS) integrating most important questions and simultaneously being brief and comprehensive. The study is planned as a multi-centric observational study. Primary endpoint is the reduction of symptom burden of patients.

The clinical study hypothesis bases on the assumption that palliative care can change the symptom burden, measured by a change in the IPOS overall profile score, and that there might be a difference in the size of the effect depending on the caring setting.

Conditions

Interventions

OTHER

specialized palliative care

specialized palliative care provided in different settings

Sponsors & Collaborators

  • St. Franziskus Hospital

    collaborator OTHER

  • Raphaelsklinik Münster

    collaborator UNKNOWN

  • Josephs Hospital Warendorf

    collaborator UNKNOWN

  • Palliativnetz Muenster gGmbH

    collaborator UNKNOWN

  • University Hospital Muenster

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-11
Primary Completion
2019-10-31
Completion
2019-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03286127 on ClinicalTrials.gov